Original Article

You have full text access to this OnlineOpen article

Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study

  1. Alok A. Khorana M.D.1,†,*,
  2. Charles W. Francis M.D.1,
  3. Eva Culakova Ph.D.1,2,
  4. Gary H. Lyman M.D., M.P.H.1,2

Article first published online: 13 NOV 2005

DOI: 10.1002/cncr.21496

Issue

Cancer

Cancer

Volume 104, Issue 12, pages 2822–2829, 15 December 2005

Additional Information

How to Cite

Khorana, A. A., Francis, C. W., Culakova, E. and Lyman, G. H. (2005), Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer, 104: 2822–2829. doi: 10.1002/cncr.21496

Author Information

  1. 1

    James P. Wilmot Cancer Center and the Department of Medicine, University of Rochester, Rochester, New York

  2. 2

    Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York

  1. †

    Fax: (585) 273-1042

*601 Elmwood Ave, Box 704, Rochester, NY 14642

Publication History

  1. Issue published online: 8 DEC 2005
  2. Article first published online: 13 NOV 2005

Funded by

  • James P. Wilmot Cancer Research Fellowship
  • The Awareness of Neutropenia in Cancer (ANC) Study Group Registry is funded by Amgen, Inc.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (156K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Elias J. Anaissie, Elizabeth A. Coleman, Julia A. Goodwin, Robert L. Kennedy, Kimberly D. Lockhart, Carol B. Stewart, Sharon K. Coon, Clyde Bailey, Bart Barlogie, Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis, Cancer, 2012, 118, 2
    Direct Link:
  2. 2
    Michael B. Streiff, Anticoagulation in the management of venous thromboembolism in the cancer patient, Journal of Thrombosis and Thrombolysis, 2011, 31, 3, 282

    CrossRef

  3. 3
    Andrew D. Blann, Simon Dunmore, Arterial and Venous Thrombosis in Cancer Patients, Cardiology Research and Practice, 2011, 2011, 1

    CrossRef

  4. 4
    A Sparsa, H Durox, V Doffoel-Hantz, E-M Munyangango, C Bédane, J Cendras, C Gantois, S Boulinguez, J-M Bonnetblanc, High prevalence and risk factors of thromboembolism in stage IV melanoma, Journal of the European Academy of Dermatology and Venereology, 2011, 25, 3
    Direct Link:
  5. 5
    C. Font, B. Farrus, L. Vidal, T. M. Caralt, L. Visa, B. Mellado, D. Tassies, J. Monteagudo, J. C. Reverter, P. Gascon, Incidental versus symptomatic venous thrombosis in cancer: a prospective observational study of 340 consecutive patients, Annals of Oncology, 2011,

    CrossRef

  6. 6
    Ryan P. Merkow, Karl Y. Bilimoria, Martin D. McCarter, Mark E. Cohen, Carlton C. Barnett, Mehul V. Raval, Joseph A. Caprini, Howard S. Gordon, Clifford Y. Ko, David J. Bentrem, Post-Discharge Venous Thromboembolism After Cancer Surgery, Annals of Surgery, 2011, 254, 1, 131

    CrossRef

  7. 7
    Alpesh N. Amin, Steven B. Deitelzweig, Prevention of venous thromboembolism in cancer patients: current approaches and opportunities for improvement, Oncology Reviews, 2011,

    CrossRef

  8. 8
    M. Chavez-MacGregor, H. Zhao, M. Kroll, S. Fang, N. Zhang, G. N. Hortobagyi, T. A. Buchholz, Y.- C. Shih, S. H. Giordano, Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer, Annals of Oncology, 2011,

    CrossRef

  9. 9
    L. A. Menapace, D. R. Peterson, A. Berry, T. Sousou, A. A. Khorana, Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer, Thrombosis and Haemostasis, 2011, 106, 2, 371

    CrossRef

  10. 10
    H. Ueba, M. Brines, M. Yamin, T. Umemoto, J. Ako, S.-i. Momomura, A. Cerami, M. Kawakami, Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin, Proceedings of the National Academy of Sciences, 2010, 107, 32, 14357

    CrossRef

  11. 11
    Ji Eun Lee, Hye-Ryoun Kim, Sang-Min Lee, Jae-Joon Yim, Chul-Gyu Yoo, Young Whan Kim, Sung Koo Han, Young-Soo Shim, Seok-Chul Yang, Clinical Characteristics of Pulmonary Embolism with Underlying Malignancy, The Korean Journal of Internal Medicine, 2010, 25, 1, 66

    CrossRef

  12. 12
    Lisa Barbera, Gillian Thomas, Erythropoiesis stimulating agents, thrombosis and cancer, Radiotherapy and Oncology, 2010, 95, 3, 269

    CrossRef

  13. 13
    R. SIMANEK, R. VORMITTAG, C. AY, G. ALGUEL, D. DUNKLER, I. SCHWARZINGER, G. STEGER, U. JAEGER, C. ZIELINSKI, I. PABINGER, High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS), Journal of Thrombosis and Haemostasis, 2010, 8, 1
    Direct Link:
  14. 14
    R. SINGH, T. SOUSOU, S. MOHILE, A. A. KHORANA, High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients, Journal of Thrombosis and Haemostasis, 2010, 8, 8
    Direct Link:
  15. 15
    C. Ay, D. Dunkler, C. Marosi, A.-L. Chiriac, R. Vormittag, R. Simanek, P. Quehenberger, C. Zielinski, I. Pabinger, Prediction of venous thromboembolism in cancer patients, Blood, 2010, 116, 24, 5377

    CrossRef

  16. 16
    Paola Giordano, Angelo Claudio Molinari, Giovanni Carlo Del Vecchio, Paola Saracco, Giovanna Russo, Maria Altomare, Paolo Perutelli, Nicoletta Crescenzio, Nicola Santoro, Marina Marchetti, Domenico De Mattia, Anna Falanga, Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia, American Journal of Hematology, 2010, 85, 5
    Direct Link:
  17. 17
    M. A. SHAH, M. CAPANU, G. SOFF, T. ASMIS, D. P. KELSEN, Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies, Journal of Thrombosis and Haemostasis, 2010, 8, 8
    Direct Link:
  18. 18
    Laurel A Menapace, Alok A Khorana, The role of thromboprophylaxis in cancer patients: emerging data, Current Opinion in Hematology, 2010, 17, 5, 450

    CrossRef

  19. 19
    V. Caruso, A. Di Castelnuovo, S. Meschengieser, M. A. Lazzari, G. de Gaetano, S. Storti, L. Iacoviello, M. B. Donati, Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events, Blood, 2010, 115, 26, 5322

    CrossRef

  20. 20
    Celso Arrais Rodrigues, Renata Ferrarotto, Roberto Kalil Filho, Yana A. S. Novis, Paulo M. G. Hoff, Venous thromboembolism and cancer: a systematic review, Journal of Thrombosis and Thrombolysis, 2010, 30, 1, 67

    CrossRef

  21. 21
    M. Mandala, S. Barni, M. Prins, R. Labianca, C. Tondini, L. Russo, A. Milesi, M. Cremonesi, M. Zaccanelli, C. Regonesi, C. Moro, A. Falanga, Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial, Annals of Oncology, 2009, 21, 4, 871

    CrossRef

  22. 22
    Suman L Sood, Cancer-associated thrombosis, Current Opinion in Hematology, 2009, 16, 5, 378

    CrossRef

  23. 23
    Keishi Sugino, Kazutoshi Isobe, Naoshi Kikuchi, Yoko Muramatsu, Go Sano, Yujiro Takai, Sakae Homma, Clinical Analysis of Lung Cancer Associated with Venous Thromboembolism, Haigan, 2009, 49, 2, 151

    CrossRef

  24. 24
    Guido Arpaia, Monica Carpenedo, Magda Verga, Ornella Mastrogiacomo, Daniele Fagnani, Mario Lanfredini, Massimo Milani, Claudio Cimminiello, D-dimer before chemotherapy might predict venous thromboembolism, Blood Coagulation & Fibrinolysis, 2009, 20, 3, 170

    CrossRef

  25. 25
    J. A. García-Erce, J. Cuenca, S. Haman-Alcober, A. A. Martínez, A. Herrera, M. Muñoz, Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study, Vox Sanguinis, 2009, 97, 3
    Direct Link:
  26. 26
    Ted Wun, Richard H. White, Epidemiology of cancer-related venous thromboembolism, Best Practice & Research Clinical Haematology, 2009, 22, 1, 9

    CrossRef

  27. 27
    Mario Mandalà, Sandro Barni, Irene Floriani, Luciano Isa, Giuseppe Fornarini, Maurizio Marangolo, Stefania Mosconi, Domenico Corsi, Eliana Rulli, Luciano Frontini, Enrico Cortesi, Alberto Zaniboni, Massimo Aglietta, Roberto Labianca, Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: The ‘GISCAD-alternating schedule’ study findings, European Journal of Cancer, 2009, 45, 1, 65

    CrossRef

  28. 28
    Parham Khosravi-Shahi, Gumersindo Pérez-Manga, International Recommendations for the Prevention and Treatment of Venous Thromboembolism Associated with Cancer, Clinical Drug Investigation, 2009, 29, 10, 625

    CrossRef

  29. 29
    Biren Saraiya, Susan Goodin, Management of Venous Thromboembolism and the Potential to Impact Overall Survival in Patients with Cancer, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009, 29, 11
    Direct Link:
  30. 30
    Giancarlo Agnelli, Gualberto Gussoni, Carlo Bianchini, Melina Verso, Mario Mandalà, Luigi Cavanna, Sandro Barni, Roberto Labianca, Franco Buzzi, Giovanni Scambia, Rodolfo Passalacqua, Sergio Ricci, Giampietro Gasparini, Vito Lorusso, Erminio Bonizzoni, Maurizio Tonato, Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study, The Lancet Oncology, 2009, 10, 10, 943

    CrossRef

  31. 31
    Francisco Javier Gonzalez Barcala, Jose Maria Garcia Prim, Milagros Moldes Rodriguez, Julio Alvarez Fernandez, Maria Jose Rey Rey, Antonio Pose Reino, Luis Valdes Cuadrado, Platelet count: association with prognosis in lung cancer, Medical Oncology, 2009, 27, 2, 357

    CrossRef

  32. You have free access to this content32
    Shalu Narang, Jason Roy, Timothy P. Stevens, Meggan Butler-O'Hara, Craig A. Mullen, Carl T. D'Angio, Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants, Pediatric Blood & Cancer, 2009, 52, 1
    Direct Link:
  33. 33
    Gregory C. Connolly, Alok A. Khorana, Risk stratification for cancer-associated venous thromboembolism, Best Practice & Research Clinical Haematology, 2009, 22, 1, 35

    CrossRef

  34. 34
    Eirini Katodritou, Meletios A. Dimopoulos, Konstantinos Zervas, Evangelos Terpos, Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma, Cancer Treatment Reviews, 2009, 35, 8, 738

    CrossRef

  35. 35
    Lisa K. Hicks, Matthew C. Cheung, Keyue Ding, Baktiar Hasan, Lesley Seymour, Aurélie Le Maître, Natasha B. Leighl, Frances A. Shepherd, Venous thromboembolism and nonsmall cell lung cancer, Cancer, 2009, 115, 23
    Direct Link:
  36. 36
    A. A. Khorana, N. M. Kuderer, E. Culakova, G. H. Lyman, C. W. Francis, Development and validation of a predictive model for chemotherapy-associated thrombosis, Blood, 2008, 111, 10, 4902

    CrossRef

  37. 37
    Naomi V. Dahl, David H. Henry, Daniel W. Coyne, Editorial Focus: Thrombosis with Erythropoietic Stimulating Agents—Does Iron-Deficient Erythropoiesis Play a Role?, Seminars in Dialysis, 2008, 21, 3
    Direct Link:
  38. 38
    C. Ay, R. Simanek, R. Vormittag, D. Dunkler, G. Alguel, S. Koder, G. Kornek, C. Marosi, O. Wagner, C. Zielinski, I. Pabinger, High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS), Blood, 2008, 112, 7, 2703

    CrossRef

  39. 39
    Benjamin Tuy, Chinmoy Bhate, Kathleen Beebe, Francis Patterson, Joseph Benevenia, IVC Filters May Prevent Fatal Pulmonary Embolism in Musculoskeletal Tumor Surgery, Clinical Orthopaedics and Related Research, 2008, 467, 1, 239

    CrossRef

  40. 40
    H. Kobayashi, S. Minatoguchi, S. Yasuda, N. Bao, I. Kawamura, M. Iwasa, T. Yamaki, S. Sumi, Y. Misao, H. Ushikoshi, K. Nishigaki, G. Takemura, T. Fujiwara, Y. Tabata, H. Fujiwara, Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair, Cardiovascular Research, 2008, 79, 4, 611

    CrossRef

  41. 41
    Aristoteles Giagounidis, Pierre Fenaux, Ghulam J. Mufti, Petra Muus, Uwe Platzbecker, Guillermo Sanz, Larry Cripe, Marie Lilienfeld-Toal, Richard A. Wells, Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes, Annals of Hematology, 2008, 87, 5, 345

    CrossRef

  42. 42
    Paolo Prandoni, Michel M. Samama, Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients, British Journal of Haematology, 2008, 141, 5
    Direct Link:
  43. 43
    Murat O. Arcasoy, The non-haematopoietic biological effects of erythropoietin, British Journal of Haematology, 2008, 141, 1
    Direct Link:
  44. 44
    C. J. M. Doggen, Thromboprophylaxis in cancer outpatients, Blood, 2008, 111, 10, 4833

    CrossRef

  45. 45
    Nicolas H. Osborne, Thomas W. Wakefield, Peter K. Henke, Venous Thromboembolism in Cancer Patients Undergoing Major Surgery, Annals of Surgical Oncology, 2008, 15, 12, 3567

    CrossRef

  46. 46
    Maithili V Rao, Charles W Francis, Alok A Khorana, Cancer Supportive Care: Advances in Therapeutic Strategies, 2008,

    CrossRef

  47. 47
    Paul A Lapchak, Dalia M Araujo, Advances in hemorrhagic stroke therapy: conventional and novel approaches, Expert Opinion on Emerging Drugs, 2007, 12, 3, 389

    CrossRef

  48. 48
    Jeffrey I. Zwicker, Barbara C. Furie, Bruce Furie, Cancer-associated thrombosis, Critical Reviews in Oncology/Hematology, 2007, 62, 2, 126

    CrossRef

  49. 49
    Frank J Papatheofanis, Comparative costs of treatment with epoetin alfa and darbepoetin alfa for anemia in the oncology and nephrology settings, Expert Review of Pharmacoeconomics & Outcomes Research, 2007, 7, 1, 59

    CrossRef

  50. 50
    Alok A. Khorana, Charles W. Francis, Eva Culakova, Nicole M. Kuderer, Gary H. Lyman, Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients, Cancer, 2007, 110, 10
    Direct Link:
  51. 51
    A. Falanga, F. R. Rickles, Management of Thrombohemorrhagic Syndromes (THS) in Hematologic Malignancies, Hematology, 2007, 2007, 1, 165

    CrossRef

  52. 52
    R. Baz, E. Walker, T.K. Choueiri, R. Abou Jawde, C. Brand, B. McGowan, E. Yiannaki, S. Andresen, M.A. Hussein, Recombinant Human Erythropoietin Is Associated with Increased Overall Survival in Patients with Multiple Myeloma, Acta Haematologica, 2007, 117, 3, 162

    CrossRef

  53. 53
    A. A. KHORANA, C. W. FRANCIS, E. CULAKOVA, N. M. KUDERER, G. H. LYMAN, Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy, Journal of Thrombosis and Haemostasis, 2007, 5, 3
    Direct Link:
  54. 54
    Hau C. Kwaan, Brian Vicuna, Thrombosis and bleeding in cancer patients, Oncology Reviews, 2007, 1, 1, 14

    CrossRef

  55. 55
    Leo R Zacharski, Cocav A Engman, Venous thromboembolism prevention in cancer patients: the search for common antecedents, Expert Opinion on Pharmacotherapy, 2007, 8, 13, 2117

    CrossRef

  56. 56
    H. T. SØRENSEN, Cancer and subsequent risk of venous thromboembolism, Journal of Thrombosis and Haemostasis, 2006, 4, 3
    Direct Link:
  57. 57
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2006, 15, 6
    Direct Link:
  58. 58
    J. Bohlius, J. Wilson, J. Seidenfeld, M. Piper, G. Schwarzer, J. Sandercock, S. Trelle, O. Weingart, S. Bayliss, B. Djulbegovic, C. L. Bennett, S. Langensiepen, C. Hyde, A. Engert, Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients, JNCI Journal of the National Cancer Institute, 2006, 98, 10, 708

    CrossRef

  59. 59
    Anna Falanga, Marina Marchetti, Oncology,
    Direct Link:
  60. 60
    Harriet O. Smith, Lejla Delic, Postoperative Surveillance and Perioperative Prophylaxis,
    Direct Link:
View Full Article (HTML) Get PDF (156K)